Nanogen Posts Increased Losses in Q2 | GenomeWeb

NEW YORK, July 31- Nanogen turned in a slight increase in revenues and a significant increase in losses during its second quarter, the company said Tuesday.

The company posted revenues for the most recent financial period of $2.7 million, up slightly from the $2.4 million in the second quarter last year. Nanogen attributed their revenue rise to sponsored research programs from the company's corporate alliances, contracts and grants with government agencies, and, to a lesser extent, sales of its NanoChip Molecular Biology Workstations and cartridges.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.